genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Lilly, Avidity to Partner on Immunology Drugs in Up-to-$440M Collaboration
News
DISCOVER-Seq Detects Off-Target CRISPR Effects
News
Breast Cancer Drug Resistance Linked to Diet High in Leucine
News
Synthetic Receptor Can Distinguish Between Male and Female Steroid Hormones
News
Gene Circuits Wired into Cells Elicit Switch-Like Behavioral Output
Insights
Insights
Top 10 Best-Selling Cancer Drugs of 2018
GWAS
Genetic Basis of Obesity Carries Weight
Insights
Liquid Biopsy: An Old Concept with a New Twist
CAR T-Cells
Preparing U.S. Healthcare Insurance for High-Cost Curative Therapies
Insights
Antibody Mimetics
A-Lists
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Insights
Top 10 Sequencing Companies
Insights
Top 10 Immuno-Oncology Collaborations
A-Lists
Top 15 Best-Selling Drugs of 2018
March 2019 Vol. 39 No. 3
Top 10 Immuno-Oncology Startups
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Lilly, Avidity to Partner on Immunology Drugs in Up-to-$440M Collaboration
News
DISCOVER-Seq Detects Off-Target CRISPR Effects
News
Breast Cancer Drug Resistance Linked to Diet High in Leucine
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Magazine
April 2019 Vol. 39 No. 4
Functional Ultrasound
Commentary
Linear DNA Crosses the Line between Tags and Therapeutics
April 2019 Vol. 39 No. 4
Nucleic Acid Extraction: Extremely Fast, Extremely Simple, Extremely Effective
April 2019 Vol. 39 No. 4
CRISPR and Beyond: Advances in Gene Therapy
April 2019 Vol. 39 No. 4
Epigenetic Therapies Return Cells to the Straight and Narrow
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Upcoming Webinars
How to Decrease Long Read Sequencing Sample QC Time by 10-Fold
Videos
The First Computer-Generated Bacterial Genome
April 2019 Vol. 39 No. 4
Functional Ultrasound
Upcoming Webinars
De-Risky Business: Assessing Biotherapeutic Off-Target and On-Target Liabilities
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
T Cells
CAR T-Cells
CAR T-Cells
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
CAR T-Cells
Preparing U.S. Healthcare Insurance for High-Cost Curative Therapies
CAR T-Cells
Address Manufacturing and Look Beyond Cancer, Panel Advises Cell and Gene Therapy Companies
CAR T-Cells
Israel’s Sheba Medical Center to Manufacture Cell Therapies Using Lonza’s Cocoon Platform
CAR T-Cells
Anticancer CAR-T Cells More Effective When Less Exhausted
CAR T-Cells
Cell Therapy Manufacturing: The Supply Chain Challenge
CAR T-Cells
Identification of Sprouty 1 and Sprouty 2 Provide Basis for New...
CAR T-Cells
Regeneron to Invest $100M in bluebird bio as Companies Partner in...
CAR T-Cells
Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition
CAR T-Cells
Amgen, MD Anderson Launch Two Cancer Collaborations
CAR T-Cells
Controllable “Swiss Army Knife” CAR T Cells Solve Key Efficacy and...
CAR T-Cells
MD Anderson, Berkeley Lights Launch Cancer Cell Therapy Company
CAR T-Cells
FDA Imposes Clinical Hold on Bellicum Lead Candidate BPX-501
CAR T-Cells
Celgene to Acquire Juno for $9B, Expanding CAR-T, TCR Presence
CAR T-Cells
Kite, Pfizer to Assess Yescarta-Utomilumab Combination in Lymphoma
CAR T-Cells
Novel Biomaterials Boost T-Cell Production
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Regeneron Pharmaceuticals demonstrated its VelocImmune technology in a study published in 2015 in Proceedings of the National Academy of Sciences showing the rapid generation of fully human neutralizing antibodies against Middle East Respiratory Syndrome coronavirus (MERS-CoV) and development of a humanized mouse model for MERS-CoV infection (pictured). Regeneron will use VelocImmune and other VelociSuite platform technologies in a collaboration with bluebird bio to develop new immune cell therapies for cancer. [Source: PNAS]](https://www.genengnews.com/wp-content/uploads/2018/08/F7large2321726613-324x160.jpg "Regeneron to Invest $100M in bluebird bio as Companies Partner in Cancer Therapies")
![Sangamo Therapeutics aims to position itself as a leader in the development of chimeric antigen receptor-modified regulatory T-cell (CAR-Treg) cell therapies for immunological diseases with its planned acquisition of TxCell. [Source: TxCell]](https://www.genengnews.com/wp-content/uploads/2018/08/ENTrIA_recognition_EN_without_entria1024x9291472362223-324x160.png "Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition")
![SUPRA CAR-T offers several advantages over existing CAR-T therapy. [Cell]](https://www.genengnews.com/wp-content/uploads/2018/08/Apr27_2018_Cell_ImprovingCarTTherapy2114263165-324x160.jpg "Controllable “Swiss Army Knife” CAR T Cells Solve Key Efficacy and Safety Issues")
